B. Riley Securities Reiterates Buy on Zymeworks, Raises Price Target to $40

Zymeworks Inc. -1.05% Post

Zymeworks Inc.

ZYME

26.41

26.41

-1.05%

0.00% Post
B. Riley Securities analyst Mayank Mamtani reiterates Zymeworks (NASDAQ: ZYME) with a Buy and raises the price target from $30 to $40.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via